Known NAFLD and cirrhosis risk alleles in PNPLA3 and TM6SF2 were also associated with both elevated cT1 and MRI-derived PDFF in our cohort. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.